There is an interesting article on the promises of therapeutic vaccines at www.pharmaceutical-business-review.com
After defining therapeutic vaccines, the article states that vaccine development is presently weighted towards cancer vaccines then outlines a history of failures in the vaccine industry. The author identifies two basic types of therapeutic vaccines described as personalized or generalized and suggests that there is a “dramatic shift in interest towards generalized vaccines.”
Insignificant sales and market acceptance along with few new products have adversely affected enthusiasm for this industry. And, regardless of some improvements, no therapeutic vaccine has yet gained regulatory approval.